REGENERON PHARMACEUTICALS, INC.: accounts_payable

Value{"amount": 599500000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Period (as of 2023-03-31)
Statuscurrent
EntityREGENERON PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001804220-23-000016
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000872589/accounts-payable/2023-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cbdafbf1-32e7-43b6-898e-a6616674fd0f

History